Linyu Zhang

Dr. Linyu Zhang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2023 in International Journal of Surgery
Verified
Journal Article
Open access
GTGang Tang
Gang Tang
LZLinyu Zhang
Linyu Zhang
LXLingying Xia
Lingying Xia
JZJie Zhang
Jie Zhang
ZWZhengQiang Wei
ZhengQiang Wei
RZRongxing Zhou
Rongxing Zhou
Background: Hypothermic oxygenated machine perfusion (HOPE) is a novel organ-preservation technology designed to optimize organ quality. However, the effects of HOPE on morbidity and mortality after liver transplantation remain unclear. This meta-analysis evaluated the potential benefits of HOPE in liver transplantation. Materials and methods: The Embase, Web of Science, PubMed, Cochrane Library, and Scopus databases were searched for articles published up to 15 June 2023 (updated on 12 August 2023). Mean differences (MDs), risk ratios (RRs), and 95% confidence intervals were calculated. Results: Eleven studies encompassing five randomized controlled trials and six matched studies were included, with a total of 1000 patients. HOPE did not reduce the incidence of major postoperative complications (RR 0.80), primary non-function (PNF) (RR 0.54), reperfusion syndrome (RR 0.92), hepatic artery thrombosis (RR 0.92), renal replacement therapy (RR 0.98), length of hospital stay (MD, −1.38 days), 1-year recipient death (RR 0.67), or intensive care unit stay (MD, 0.19 days) after liver transplantation. HOPE reduced the incidence of biliary complications (RR 0.74), non-anastomotic biliary strictures (NAS) (RR 0.34), early allograft dysfunction (EAD) (RR 0.54), and acute rejection (RR 0.54). In addition, HOPE improved the retransplantation (RR 0.42) and 1-year graft loss rates (RR 0.38). Conclusions: Compared with static cold storage (SCS), HOPE can reduce the incidence of biliary complications, NAS, EAD, and acute rejection and retransplantation rate after liver transplantation and improve the 1-year graft loss rate. These findings suggest that HOPE, when compared to SCS, can contribute to minimizing complications and enhancing graft survival in liver transplantation. Further research is needed to investigate long-term outcomes and confirm the promising advantages of HOPE in liver transplantation settings.

11 July 2024 in International Journal of Surgery
Verified
Journal Article
Open access
GTGang Tang
Gang Tang
LZLinyu Zhang
Linyu Zhang
LXLingying Xia
Lingying Xia
JZJie Zhang
Jie Zhang
RCRui Chen
Rui Chen
RZRongxing Zhou
Rongxing Zhou
Background: Complicated appendicitis is associated with high morbidity, mortality, and healthcare costs. However, the relationship of preoperative in-hospital delay >24 h with complicated appendicitis and postoperative morbidity remains unclear. This meta-analysis investigated the effects of preoperative in-hospital delay on complicated appendicitis and postoperative morbidity in patients with acute appendicitis. Materials and methods: This study adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 and A MeaSurement Tool to Assess systematic Reviews 2 (AMSTAR2) guidelines. The PubMed, Embase, Cochrane Library, and Web of Science databases up to October 14, 2023 (updated on March 16, 2024) were searched for randomized controlled trials and observational studies that evaluated the effect of preoperative in-hospital delays of >24 h on acute appendicitis. Odds ratios (OR) and 95% confidence intervals (CIs) were also determined. Results: We yielded 18 130 records, of which 28 studies (512 881 patients) were included in the meta-analysis. The risk of bias was considered serious, moderate, and low for 24, 3, and 1 study, respectively. Although preoperative in-hospital delays of >24 h were not associated with a higher risk of surgical-site infection (OR: 1.04, 95% CI: 0.97, 1.12, P =0.25), in-hospital delays of >24 h were a risk factor for complicated appendicitis (OR: 1.60, 95% CI: 1.25, 2.05, P =0.0002), and postoperative complications (OR: 1.51, 95% CI: 1.30, 1.75, P 24 h before surgery increased the OR of postoperative mortality (OR: 1.81, 95% CI: 1.33, 2.45, P =0.0001). The sensitivity analyses also confirmed the robustness of our results. Conclusions: An in-hospital delay of >24 h is a risk factor for complicated appendicitis, postoperative complications, and mortality. Given the subsequent adverse outcomes of in-hospital delays, appendectomy should not be delayed for >24 h.

27 June 2024 in International Journal of Surgery
Verified
Journal Article
Open access
GTGang Tang
Gang Tang
LZLinyu Zhang
Linyu Zhang
LXLingying Xia
Lingying Xia
JZJie Zhang
Jie Zhang
RCRui Chen
Rui Chen
RZRongxing Zhou
Rongxing Zhou
Background: Robotic pancreaticoduodenectomy (RPD) is used more commonly, but this surge is mostly based on observational data. This meta-analysis aimed to compare the short-term outcomes between RPD and open pancreaticoduodenectomy (OPD) using data collected from randomized controlled trials (RCTs) and propensity-score-matched (PSM) studies. Methods: We searched PubMed, Cochrane Library, Embase, and Web of Science databases for RCTs and PSM studies comparing RPD and OPD. Risk ratios (RRs) and mean differences (MDs) with 95% confidence intervals (CIs) were calculated. Results: Twenty-four studies, encompassing two RCTs and 22 PSM studies, were included, with a total of 9393 patients (RPD group: 3919 patients; OPD group: 5474 patients). Although RPD was associated with a longer operative time (MD, 61.61 min), patients may benefit from reduced blood loss (MD, −154.05 ml), shorter length of stay (MD, −1.60 days), lower blood transfusion rate (RR, 0.85), and wound infection rate (RR, 0.61). There were no significant differences observed in 30-day readmission (RR, 0.99), 90-day mortality (RR, 0.97), overall morbidity (RR, 0.88), major complications (RR, 1.01), reoperation (RR, 1.08), bile leak (RR, 1.01), chylous leak (RR, 0.98), postoperative pancreatic fistula (RR, 0.97), post-pancreatectomy hemorrhage (RR, 1.15), delayed gastric emptying (RR, 0.88), number of harvested lymph nodes (MD, −0.12), and R0 resection (RR, 1.01) between the groups. Conclusions: Although some short-term outcomes were similar between RPD and OPD, RPD exhibited reduced intraoperative blood loss, shorter hospital stays, lower wound infection, and blood transfusion rates. In the future, RPD may become a safe and effective alternative to OPD.

20 June 2022 in Nutrition and Cancer
Verified
Journal Article
Closed access
GTGang Tang
Gang Tang
LZLinyu Zhang
Linyu Zhang
WHWang Huang
Wang Huang
ZWZhengQiang Wei
ZhengQiang Wei
Postoperative infection of hepatopancreatobiliary cancer (HPBC) is a major cause of morbidity and mortality. Probiotics and synbiotics are potential prevention strategies, but evidence on the effic...

30 June 2022 in Nutrition and Cancer
Verified
Journal Article
Closed access
GTGang Tang
Gang Tang
LZLinyu Zhang
Linyu Zhang
WHWang Huang
Wang Huang
ZWZhengQiang Wei
ZhengQiang Wei
Objective Anemia is common and harmful in patients undergoing colorectal cancer (CRC) surgery. Blood transfusion (BT) is used to treat anemia, but results in a poor oncology prognosis. Iron supplementation may be effective in improving anemia and reducing the need for BT, however, the results remain controversial. This meta-analysis was conducted to evaluate the efficacy of iron supplementation in improving hemoglobin concentrations (Hb) and reducing the need for BT. Methods Up to February 10, 2021, PubMed, Web of Science, Cochrane Library, Embase databases were searched for studies evaluating the effects of iron supplementation on CRC surgery patients. Meta-analysis was conduct using the random-effects model. Results Seven trials with 879 participants in total were included in the meta-analysis. The pooled findings suggested that iron supplementation effectively increased Hb (MD 0.41; 95% CI: 0.12, 0.69, P = 0.006) and reduced the risk of BT (RR 0.60, 95% CI 0.45, 0.78, P = 0.0002) compared with the control group. In addition, subgroup analyses showed that these benefits were observed with both oral and intravenous iron supplementation. Conclusion Iron supplementation is effective in ameliorating anemia and reducing the need for BT in CRC surgery patients.

26 July 2021 in Nutrition and Cancer
Verified
Journal Article
Closed access
GTGang Tang
Gang Tang
LZLinyu Zhang
Linyu Zhang
WHWang Huang
Wang Huang
ZWZhengQiang Wei
ZhengQiang Wei
The rapid and widespread global pandemic of 2019 coronavirus disease (COVID-19) has had unprecedented negative health and economic impacts. Immune responses play a key role in the development of COVID-19, including the disruption of immune balance and cytokine storms caused by excessive inflammatory responses. Due to the effects of cancer itself and treatment, patients often accompanied by immunosuppression appear to be a susceptible population for COVID-19. Worryingly, COVID-19 with cancer is associated with a poor prognosis. Cancer patients are a vulnerable group, threatened by COVID-19, finding a way to combat COVID-19 for them is urgent. Immunonutrition is closely related to balance and strong immune function. Supplementary immunonutrition can improve the immune function and inflammatory response of cancer patients after surgery, which provides evidence for the role of immunonutrition in combating COVID-19. We reviewed possible mechanisms of immunonutrition against COVID-19, including enhancing immune cell function, increasing immune cell count, ameliorating excessive inflammatory response, and regulating gut microbiota. Immunonutrition supplementation in cancer patients may be beneficial to enhance immune function in the early stage of COVID-19 infection and control excessive inflammatory response in the late stage. Therefore, immunonutrition is a potential strategy for the prevention and treatment of COVID-19 in cancer.